Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2021

Apr 30, 2021

29777_dirs_2021-04-30_105edfae-b821-444f-b287-57f200229320.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2021-04-28

Reporting Person: Funck Robert E (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-28 Common shares without par value G 700 Disposed 188650 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 10000 Indirect
Common shares without par value 10000 Indirect
Common shares without par value 17821 Indirect
Common shares without par value 500 Indirect

Footnotes

F1: Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of April 28, 2021.

F3: The reporting person disclaims beneficial ownership of all securities held by his daughter.